Tag: impact

Categories
Resource Centre - Publications

Results Report 2022

When COVID-19 emerged in early 2020, the Global Fund took swift action to fight the pandemic and protect hard-won gains against HIV, tuberculosis (TB) and malaria. With the support of our generous donors, we have since awarded more than US$4.4 billion to help countries respond to the new virus, mitigate its impact on lifesaving HIV, TB and malaria services and make urgent improvements to health systems. While we were not able to prevent COVID-19 from having a massive impact on people living in low- and middle-income countries, including both the direct impact of the new virus and the reversal of hard-won gains against HIV, TB and malaria, it could have been much worse.

We saw the benefits of the interventions we made in 2021, with gains in key programmatic results across all three diseases. The Global Fund’s Results Report 2022 details how our partnership played a critical role in supporting countries and communities to respond to the pandemic and continue the progress in the fight against HIV, TB and malaria.

Download Report


Categories
Resource Centre - Publications

The Impact of COVID-19 On HIV, TB And Malaria Services and Systems For Health: A Snapshot from 502 Health Facilities across Africa and Asia

The impact of COVID-19 on HIV, TB and Malaria Services and Systems for Health: A snapshot from 502 health facilities across Africa and Asia.

Download Document


Categories
Related Resources Resource Centre - Reports

ACT-Accelerator Outcomes Report, 2020-22

This report provides information on cumulative achievements of the ACT-Accelerator partnership since the start of the pandemic to end September 2022, an account of the outcomes of the four Pillars’ work towards the milestones set out in the 2021-22 Strategic Plan, and incorporates the regular Q3 Update. Additionally, six Impact Stories demonstrate the real-world impact of the partnership in countries, focusing on areas such as expanding access to medical oxygen, accelerating vaccine delivery and rolling out test and treat pilots.

Download Document


Categories
Related Resources Resource Centre - Reports

ACT-Accelerator: Quarterly Update Q2: 1 April – 30 June 2022

The Q2 Update charts progress achieved by ACTAccelerator partners between 1 April and 30 June 2022. The partners responded collectively to the global evolution of the pandemic and provided continued support to low- and middle-income countries with the development, procurement, and delivery of COVID-19 tests, treatments, personal protective equipment (PPE) and vaccines.

Data are drawn from the ACT-Accelerator and Multilateral Leaders Task Force Global COVID-19 Access Tracker (GCAT) which tracks country access to COVID-19 tools. Data is also drawn from WHO Coronavirus (COVID-19) Dashboard, UNICEF COVID-19 Vaccine Market Dashboard, and consolidated reports from each of the ACT-Accelerator Pillars and the Health Systems and Response Connector.

This Q2 Update features a profile of Cambodia’s remarkable vaccine distribution success and the support of ACT-Accelerator agencies in equipping the country with COVID-19 tools to accelerate the country’s path to recovery.

Download Document

Categories
Resource Centre - Reports

ACT-Accelerator: Quarterly Update Q1: 1 January – 31 March 2022

The Q1 Update charts progress achieved by ACT-Accelerator partners between 1 January and 31 March 2022 as they responded collectively to the global evolution of the pandemic and continued to support low-and middle-income countries with the development, procurement, and delivery of COVID-19 tests, treatments, personal protective equipment (PPE) and vaccines.

Data are drawn from the ACT-Accelerator and Multilateral Leaders Task Force Global COVID-19 Access Tracker (GCAT), which tracks country access to COVID-19 tools. Data is also drawn from the WHO Coronavirus (COVID-19) Dashboard, UNICEF COVID-19 Vaccine Market Dashboard, and consolidated reports from each of the ACT-Accelerator Pillars and the Health Systems and Response Connector.

This Q1 Update features a profile of Senegal and highlights how ACT-Accelerator partners have boosted the country’s national COVID-19 response.

A snapshot of vaccine delivery in Ethiopia is also provided as an illustration of progress through collaboration in a challenging context.

Download Document

Categories
Resource Centre - Reports

The ACT-Accelerator: Two years of impact

The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.

Highlights of the partnership’s achievements include: enabling 40 countries to begin their COVID-19 vaccination campaigns, delivering over 1.4 billion vaccine doses to 145 countries through COVAX, helping build the sequencing capacity in Southern Africa that first detected the Omicron variant, and negotiating unprecedented deals with the world’s largest oxygen suppliers to increase access in more than 120 low- and middle-income countries. 

The report also looks ahead at the partnership’s push to close its urgent financing gap and focus on ensuring access to scarce tools, scaling up delivery and uptake in countries, and informing deliberations on the future global health security architecture.

COVID-19 can only be downgraded as a global threat once vaccines and new antivirals are rolled out equitably, with robust systems of testing and sequencing built up, so new variants can be detected early and responses quickly adapted.

The report emphasises the need for countries to act in solidarity to end the acute phase of the pandemic and highlights the ACT-Accelerator’s vital work in making this happen.

Download Document

Categories
Resource Centre - Reports

ACT-Accelerator: Quarterly Update Q4: 1 October – 31 December 2021

The Q4 Update charts progress achieved by ACT- Accelerator partners between 1 October and 31 December 2021 as they responded collectively to the global evolution of the pandemic and continued to support low- and middle-income countries with the development, procurement and delivery of COVID-19 tests, treatments, personal protective equipment (PPE) and vaccines.

Data is drawn from the ACT-Accelerator and Multilateral Leaders Task Force Global COVID-19 Access Tracker (GCAT)1 which tracks country access to COVID-19 tools. 

Data is also drawn from WHO Coronavirus (COVID-19) Dashboard2, UNICEF COVID-19 Vaccine Market Dashboard and consolidated reports from each of the ACT-Accelerator partners.

This Q4 Update features a profile of Honduras and describes how ACT-Accelerator partners have helped mitigate the impact of the pandemic and supported the national COVID-19 response in a country challenged with ongoing humanitarian crises.

Download Document

Categories
Resource Centre - Reports

ACT Accelerator: Quarterly Update Q3: 1 July – 30 September 2021

Note: Report updated on 15 Sept 2021 with removal of reference to the average price of antigen RDTs on page 3, removal of reference to price reductions in diagnostics on page 4, and the addition of references to US$ 202m in funding for in-country vaccine delivery on pages 2 and 8.

Download Document

Update: the Q3 2021 Quarterly Update can be found here. 

Categories
Resource Centre - Reports

ACT Accelerator: Quarterly Update Q2: 1 April – 30 June 2021

9 March 2022: The Q3 Update was amended to ensure that values for diagnostics, treatments and PPE procured, delivered, and funds awarded to countries are in line with the WHO Supply Chain Database data, and to reflect cumulative amounts since the start of the pandemic rather than for the 2021 calendar year. The introduction to the Health Systems & Response Connector section was amended to include the Global Financing Facility. 

Download Document